R. Woods
Director/Board Member presso X4 PHARMACEUTICALS, INC.
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Attualmente, R. Keith Woods ricopre la posizione di Chief Operating Officer di argenx SE. Nella sua carriera passata ha ricoperto la posizione di SVP-North American Operations presso Alexion Pharmaceuticals, Inc. e di vicepresidente e amministratore delegato presso Alexion Pharma UK Ltd. (una filiale di Alexion Pharmaceuticals, Inc.). (una filiale di Alexion Pharmaceuticals, Inc.). Si è laureato alla Florida State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ARGEN-X SE
0.01% | 20/02/2024 | 3 307 ( 0.01% ) | 1 M $ | 31/03/2024 |
X4 PHARMACEUTICALS, INC.
0.05% | 16/10/2023 | 90 000 ( 0.05% ) | 125 100 $ | 31/03/2024 |
Posizioni attive di R. Woods
| Società | Posizione | Inizio |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Director/Board Member | 16/10/2023 |
| TSCAN THERAPEUTICS, INC. | Director/Board Member | 06/12/2023 |
| ROCKET PHARMACEUTICALS, INC. | Director/Board Member | 12/12/2023 |
Precedenti posizioni note di R. Woods
| Società | Posizione | Fine |
|---|---|---|
| ARGENX SE | Chief Operating Officer | 13/03/2023 |
Alexion Pharma UK Ltd.
 Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Part of AstraZeneca PLC, Alexion Pharma UK Ltd. is a pharmaceutical wholesaler founded in 2006. The private company is based in Middlesex, UK. | Corporate Officer/Principal | - |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formazione di R. Woods
| Florida State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| ARGENX SE | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Alexion Pharma UK Ltd.
Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Part of AstraZeneca PLC, Alexion Pharma UK Ltd. is a pharmaceutical wholesaler founded in 2006. The private company is based in Middlesex, UK. | Distribution Services |
- Borsa valori
- Insiders
- R. Woods
